Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
NASDAQ:VIVO
Price:
33.97 USD
Market Closed
Updated:
May 11, 2024
P/OCF
Price to OCF
Price to OCF
18
Current
15.1
Median
15.6
Industry
Higher
than median
Higher
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=18
Market Cap
/
1.5B
Operating Cash Flow
82.4m
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Meridian Bioscience Inc
NASDAQ:VIVO
|
1.5B USD | 18 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.3T JPY | 31 | |
| CH |
|
Alcon AG
SIX:ALC
|
36.3B CHF | 28.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
190B DKK | 34.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 26 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 33.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | -117.5 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 40.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 18.3 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 13.7 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 67.7 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
